Monoclonal gammopathy of undetermined significance laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
#[[Plasma cell]]s less than 10% on [[bone marrow examination]]; and | #[[Plasma cell]]s less than 10% on [[bone marrow examination]]; and | ||
#No evidence of bone lesions, [[anemia]], [[hypercalcemia]], or [[renal insufficiency]] related to the paraprotein. | #No evidence of bone lesions, [[anemia]], [[hypercalcemia]], or [[renal insufficiency]] related to the paraprotein. | ||
Check the blood for [[hypercalcemia]] and deterioration in [[renal function]], check the urine for[[Bence-Jones]] protein | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:31, 21 September 2012
Monoclonal gammopathy of undetermined significance Microchapters |
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Monoclonal gammopathy of undetermined significance laboratory findings On the Web |
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance laboratory findings |
FDA on Monoclonal gammopathy of undetermined significance laboratory findings |
on Monoclonal gammopathy of undetermined significance laboratory findings |
Monoclonal gammopathy of undetermined significance laboratory findings in the news |
Blogs on Monoclonal gammopathy of undetermined significance laboratory findings |
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
Patients may be diagnosed with MGUS if they fulfill the following three criteria:[1]
- A monoclonal paraprotein band less than 3 g/dl;
- Plasma cells less than 10% on bone marrow examination; and
- No evidence of bone lesions, anemia, hypercalcemia, or renal insufficiency related to the paraprotein.
Check the blood for hypercalcemia and deterioration in renal function, check the urine forBence-Jones protein
References
- ↑ International Myeloma Working Group (2003). "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group". Br J Haematol. 121 (5): 749–57. PMID 12780789.